Disclaimer

These materials are intended to be used as examples only of documents to help you implement a school-based vaccination initiative in your school district.

Please note: These materials must be customized to reflect your individual initiative and to ensure compliance with any legal/policy requirements applicable to your initiative.

These materials are not intended to be a substitute for or an influence upon the independent, clinical judgment of the healthcare professional overseeing your vaccination initiative.

Proceed Cancel

Why Vaccinate?

Because fewer kids with flu means more kids in school.

Did you know that in the US, the flu caused 38 million missed school days in 1 year?1

That's right — research shows that the flu easily spreads in the school environment, which is bad news for students, families, and communities.2,3

But we can learn as much as possible and take action against the flu. Click below to get the facts.

Children and the Flu

With such low vaccination levels and close contact to each other, it's no wonder children are primary flu spreaders.2-5

Learn More

Vaccination Recommendations

The Centers for Disease Control and Prevention (CDC) guidelines have changed. Find out how — then spread the awareness.2


Learn More

Register Now

Receive important updates to help you Teach Flu a Lesson

Register now

Teach the Importance of Vaccinating.

Download the full presentation



Important Safety and Eligibility Information

Who may be eligible for FluMist®?

FluMist is a vaccine approved for the prevention of certain types of influenza disease in children, adolescents and adults 2-49 years of age. FluMist may not protect everyone who gets it. FluMist is for intranasal administration only.


Who may not be able to get FluMist?

FluMist is not right for everyone. FluMist must not be given to: people with history of hypersensitivity to eggs, egg proteins, gentamicin, gelatin or arginine; people with life-threatening reactions to previous influenza vaccinations; and children and adolescents receiving aspirin or aspirin-containing therapy.


Children less than 24 months of age are not eligible for FluMist.


The following people may not be able to get FluMist or may be able to get it only in certain situations: people with asthma or active wheezing, or children less than 5 years of age with recurrent wheezing; people with a history of Guillain-Barré syndrome; people with a weakened immune system; people with long-term medical conditions including heart disease, kidney disease, and metabolic diseases, such as diabetes; and pregnant women.


If you or your child fall into one of these groups, be sure to tell your healthcare provider. They will decide if FluMist is right for you or your child.


What are the most common side effects of FluMist?

Most common side effects included runny nose or nasal congestion, sore throat, and fever. For a full list of side effects, please see section 6.1 in the following product information.


Please see accompanying complete product information, including information for patients, or visit www.FluMist.com.


References

1. Adams PF, Hendershot GE, Marano MA. Centers for Disease Control and Prevention/National Center for Health Statistics. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat. 1999;10:1-203. 2. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR. 2009;58(RR-08):1-52. 3. Weycker D, Edelsberg J, Halloran ME, et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine. 2005;23:1284-1293. 4. Centers for Disease Control and Prevention. Influenza vaccination coverage levels: 2008-2009. http://www.cdc.gov/flu/professionals/acip/coveragelevels.html. Accessed May 12, 2010. 5. Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA. Influenza virus infection in infants. Pediatr Infect Dis J. 1997;16:1065-1068. 6. Glezen WP, Couch RB. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med. 1978;298:587-592.